Market Overview:
The global solifenacin succinate market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of urinary incontinence, rising geriatric population, and growing demand for minimally invasive procedures. By type, the market is segmented into more than or equal to 99% and < 99%. The < 99% segment is expected to grow at a higher CAGR during the forecast period. By application, the market is divided into tablet, capsule, and other applications. The tablet segment dominates the global solifenacin succinate market owing to its high usage in clinical settings. Geographically, North America dominates the global solifenacin succinate market followed by Europe and Asia Pacific.
Product Definition:
Solifenacin succinate is a drug that is used to treat overactive bladder. It helps to control the symptoms of urinary urgency, frequency, and incontinence.
More than or euqal to 99%:
Solifenacin succinate is a more than or euqal to 99% solute. It's an oral drug used for the treatment of chronic and acute-onset cough associated with asthma in patients 12 years of age and older. The global demand for Solifenacin succinate was 1,500 tons in 2016 and it is expected to grow at a CAGR of XX% over the forecast period (2017 - 2027).
< 99%:
The solifenacin succinate product segment has been identified as the fastest growing generic medicine market. The growth is attributed to factors such as increasing incidences of chronic pain disorders, rising awareness about self-medication among patients and healthcare practitioners, and increasing penetration of online pharmacies.
Application Insights:
Solifenacin succinate is used for the treatment of various skin conditions, such as acne, rosacea, hyperpigmentation and others. The product finds application in the form of a cream or gel for topical application on the skin. It is also available in oral tablets or capsules for external use on the skin. Other applications include ophthalmic solution and ear drops among others. Acne affects nearly 90% of adolescents and 95% of them suffer from acne scars after completion of their teenage years.
Regional Analysis:
North America dominated the global market in 2017 owing to the high prevalence of chronic obstructive pulmonary disease (COPD) and other respiratory diseases. In addition, increasing awareness about various treatment options is expected to fuel the regional market growth over the forecast period.
Asia Pacific is expected to be one of the fastest-growing regions during the forecast period due to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China, India, South Korea & Japan. Moreover, economic development coupled with growing pharmaceutical industry will also boost product demand over next eight years. For instance, Sun Pharmaceutical Industries Limited has introduced solifenacin succinate tablets under brand name VESIcare in India for treating COPD symptoms including cough and congestion; these factors are likely to contribute toward regional growth during 2018 - 2030 time frame.
Growth Factors:
- Increasing geriatric population: The global geriatric population is increasing at a rapid pace. This is expected to drive the demand for solifenacin succinate in the coming years.
- Rising prevalence of bladder dysfunction: The prevalence of bladder dysfunction is on the rise, owing to factors such as aging, obesity, and smoking. This is likely to boost the demand for solifenacin succinate in the near future.
- Growing awareness about overactive bladder syndrome: There is a growing awareness among people about overactive bladder syndrome (OAB). This is likely to create opportunities for players operating in the solifenacin succinate market in the coming years.
- Technological advancements: With technological advancements taking place at a rapid pace, players are introducing novel products with enhanced features into the market space, which is expected to fuel growth of this market during forecast period 2017-2025 . 5) Availability of generic versions: A number of generic versions are available for solifenacin succinate across different regions worldwide owing to patent expiry of key patents covering this product
Scope Of The Report
Report Attributes
Report Details
Report Title
Solifenacin Succinate Market Research Report
By Type
More than or euqal to 99%, < 99%
By Application
Tablet, Capsule, Other
By Companies
Astellas Pharma, Sun Pharmaceutical Industries, Tapi Teva, Enantiotech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Solifenacin Succinate Market Report Segments:
The global Solifenacin Succinate market is segmented on the basis of:
Types
More than or euqal to 99%, < 99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tablet, Capsule, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Astellas Pharma
- Sun Pharmaceutical Industries
- Tapi Teva
- Enantiotech
Highlights of The Solifenacin Succinate Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- More than or euqal to 99%
- < 99%
- By Application:
- Tablet
- Capsule
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Solifenacin Succinate Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Solifenacin succinate is a medication used to treat pain and inflammation. It is available as a tablet, capsule, or liquid form. Solifenacin succinate works by blocking the action of certain chemicals in the body that can cause pain and inflammation.
Some of the major players in the solifenacin succinate market are Astellas Pharma, Sun Pharmaceutical Industries, Tapi Teva, Enantiotech.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Solifenacin Succinate Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Solifenacin Succinate Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Solifenacin Succinate Market - Supply Chain
4.5. Global Solifenacin Succinate Market Forecast
4.5.1. Solifenacin Succinate Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Solifenacin Succinate Market Size (000 Units) and Y-o-Y Growth
4.5.3. Solifenacin Succinate Market Absolute $ Opportunity
5. Global Solifenacin Succinate Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Solifenacin Succinate Market Size and Volume Forecast by Type
5.3.1. More than or euqal to 99%
5.3.2. < 99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Solifenacin Succinate Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Solifenacin Succinate Market Size and Volume Forecast by Application
6.3.1. Tablet
6.3.2. Capsule
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Solifenacin Succinate Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Solifenacin Succinate Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Solifenacin Succinate Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Solifenacin Succinate Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Solifenacin Succinate Demand Share Forecast, 2019-2026
9. North America Solifenacin Succinate Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Solifenacin Succinate Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Solifenacin Succinate Market Size and Volume Forecast by Application
9.4.1. Tablet
9.4.2. Capsule
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Solifenacin Succinate Market Size and Volume Forecast by Type
9.7.1. More than or euqal to 99%
9.7.2. < 99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Solifenacin Succinate Demand Share Forecast, 2019-2026
10. Latin America Solifenacin Succinate Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Solifenacin Succinate Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Solifenacin Succinate Market Size and Volume Forecast by Application
10.4.1. Tablet
10.4.2. Capsule
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Solifenacin Succinate Market Size and Volume Forecast by Type
10.7.1. More than or euqal to 99%
10.7.2. < 99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Solifenacin Succinate Demand Share Forecast, 2019-2026
11. Europe Solifenacin Succinate Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Solifenacin Succinate Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Solifenacin Succinate Market Size and Volume Forecast by Application
11.4.1. Tablet
11.4.2. Capsule
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Solifenacin Succinate Market Size and Volume Forecast by Type
11.7.1. More than or euqal to 99%
11.7.2. < 99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Solifenacin Succinate Demand Share, 2019-2026
12. Asia Pacific Solifenacin Succinate Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Solifenacin Succinate Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Solifenacin Succinate Market Size and Volume Forecast by Application
12.4.1. Tablet
12.4.2. Capsule
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Solifenacin Succinate Market Size and Volume Forecast by Type
12.7.1. More than or euqal to 99%
12.7.2. < 99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Solifenacin Succinate Demand Share, 2019-2026
13. Middle East & Africa Solifenacin Succinate Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Solifenacin Succinate Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Solifenacin Succinate Market Size and Volume Forecast by Application
13.4.1. Tablet
13.4.2. Capsule
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Solifenacin Succinate Market Size and Volume Forecast by Type
13.7.1. More than or euqal to 99%
13.7.2. < 99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Solifenacin Succinate Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Solifenacin Succinate Market: Market Share Analysis
14.2. Solifenacin Succinate Distributors and Customers
14.3. Solifenacin Succinate Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Astellas Pharma
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sun Pharmaceutical Industries
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Tapi Teva
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Enantiotech
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
